1. New strategic market segment and follow-on orders continue to strengthen Aspirals position in China
- Author
-
Simon Atkinson
- Subjects
2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Outbreak ,Energy Engineering and Power Technology ,International trade ,General Chemistry ,medicine.disease_cause ,Article ,Industrial and Manufacturing Engineering ,ComputingMilieux_GENERAL ,Market segmentation ,medicine ,Position (finance) ,General Materials Science ,Electrical and Electronic Engineering ,business ,China ,Coronavirus ,General Environmental Science ,Food Science - Abstract
As reported previously in this newsletter, Fluence Corp Ltd's Aspiral™ family of decentralised, smart packaged wastewater treatment systems is being used worldwide, including countries such as China, where it is already being employed in numerous applications. Here, we briefly look at some recent developments in this country, where interest in this technology continues to grow. As an aside, the company has also provided an update regarding its operations in China and how they are potentially affected by the outbreak of the coronavirus.
- Published
- 2020
- Full Text
- View/download PDF